bit.bio

Bit.bio develops a cell coding platform that uses synthetic biology to program human induced pluripotent stem cells (iPSCs) into specific cell types, such as neurons, muscle, and liver cells. The company provides these deterministically programmed cells and disease models to researchers and pharmaceutical companies for drug discovery and phenotypic screening. Their services also include CRISPR-based functional genomics screening and custom cell development for neurodegenerative and neuromuscular research.